Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30086054HIVENSG00000105810.10protein_codingCDK6YesNo1021Q00534
TVIS30018444HIVENSG00000105810.10protein_codingCDK6YesNo1021Q00534
TVIS30067486HIVENSG00000105810.10protein_codingCDK6YesNo1021Q00534
TVIS30067487HIVENSG00000105810.10protein_codingCDK6YesNo1021Q00534
TVIS30067488HIVENSG00000105810.10protein_codingCDK6YesNo1021Q00534
TVIS30067489HIVENSG00000105810.10protein_codingCDK6YesNo1021Q00534
TVIS30067490HIVENSG00000105810.10protein_codingCDK6YesNo1021Q00534
TVIS30067491HIVENSG00000105810.10protein_codingCDK6YesNo1021Q00534
TVIS30067492HIVENSG00000105810.10protein_codingCDK6YesNo1021Q00534
TVIS30021670HIVENSG00000105810.10protein_codingCDK6YesNo1021Q00534
TCGA Plot Options
Drug Information
GeneCDK6
DrugBank IDDB12001
Drug NameAbemaciclib
Target IDBE0002212
UniProt IDQ00534
Regulation Typeinhibitor
PubMed IDs24919854
CitationsGelbert LM, Cai S, Lin X, Sanchez-Martinez C, Del Prado M, Lallena MJ, Torres R, Ajamie RT, Wishart GN, Flack RS, Neubauer BL, Young J, Chan EM, Iversen P, Cronier D, Kreklau E, de Dios A: Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine. Invest New Drugs. 2014 Oct;32(5):825-37. doi: 10.1007/s10637-014-0120-7. Epub 2014 Jun 13.
GroupsApproved; Investigational
Direct ClassificationBenzimidazoles
SMILESCCN1CCN(CC2=CC=C(NC3=NC=C(F)C(=N3)C3=CC(F)=C4N=C(C)N(C(C)C)C4=C3)N=C2)CC1
Pathways
PharmGKBPA166153471
ChEMBLCHEMBL3301610